Skip to content

Insider · CIK 0001746342

Chang Carmen

Reports to the SEC for 16 companies · MENLO PARK, CA

Transactions

50

Companies

16

Filings

5

CIK

0001746342

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2026-06-11COURCoursera, Inc.A Award—
2026-03-10KRROKorro Bio, Inc. · Pre-Funded WarrantsP Purchase+$2.7M
2026-03-10KRROKorro Bio, Inc.P Purchase+$2.3M
2026-02-09SGPSpyGlass Pharma, Inc.C Conversion—
2026-02-09SGPSpyGlass Pharma, Inc.C Conversion—
2026-02-09SGPSpyGlass Pharma, Inc. · Series B Preferred StockC Conversion—
2026-02-09SGPSpyGlass Pharma, Inc. · Series B Preferred StockC Conversion—
2026-02-09SGPSpyGlass Pharma, Inc.C Conversion—
2026-02-09SGPSpyGlass Pharma, Inc. · Series C-2 Preferred StockC Conversion—
2026-02-09SGPSpyGlass Pharma, Inc. · Series C-1 Preferred StockC Conversion—
2026-02-09SGPSpyGlass Pharma, Inc.P Purchase+$15M
2026-02-09SGPSpyGlass Pharma, Inc. · Series D Preferred StockC Conversion—
2026-02-09SGPSpyGlass Pharma, Inc.C Conversion—
2026-02-09SGPSpyGlass Pharma, Inc.C Conversion—
2026-02-09SGPSpyGlass Pharma, Inc.C Conversion—
2026-02-09SGPSpyGlass Pharma, Inc. · Series A Preferred StockC Conversion—
2025-10-02NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money—
2025-10-02NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion—
2025-10-02NEUENeueHealth, Inc. · Series A Convertible Perpetual Preferred StockD Disposition to Issuer—
2025-10-02NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money—
2025-10-02NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award—
2025-10-02NEUENeueHealth, Inc.S Sale−$6,075
2025-10-02NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award—
2025-10-02NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award—
2025-10-02NEUENeueHealth, Inc.S Sale−$16.6K
2025-10-02NEUENeueHealth, Inc.X Exercise of In-Money+$1,891.95
2025-10-02NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money—
2025-10-02NEUENeueHealth, Inc.D Disposition to Issuer—
2025-10-02NEUENeueHealth, Inc.X Exercise of In-Money+$6,075.36
2025-10-02NEUENeueHealth, Inc.S Sale−$1,890
2025-10-02NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion—
2025-10-02NEUENeueHealth, Inc.M Exercise/Conversion+$1,861.28
2025-10-02NEUENeueHealth, Inc.M Exercise/Conversion+$1,240.85
2025-10-02NEUENeueHealth, Inc.X Exercise of In-Money+$16.6K
2025-10-02NEUENeueHealth, Inc. · Series B Convertible Perpetual Preferred StockD Disposition to Issuer—
2025-10-02NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money—
2025-10-02NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion—
2025-10-02NEUENeueHealth, Inc.F Tax Payment−$1,863
2025-10-02NEUENeueHealth, Inc.M Exercise/Conversion+$3,722.55
2025-10-02NEUENeueHealth, Inc. · Series B Convertible Perpetual Preferred StockD Disposition to Issuer—
2025-10-02NEUENeueHealth, Inc.F Tax Payment−$3,719.25
2025-10-02NEUENeueHealth, Inc.S Sale−$1,890
2025-10-02NEUENeueHealth, Inc.D Disposition to Issuer—
2025-10-02NEUENeueHealth, Inc.F Tax Payment−$1,228.5
2025-10-02NEUENeueHealth, Inc.X Exercise of In-Money+$1,891.95
2025-10-02NEUENeueHealth, Inc. · Series A Convertible Perpetual Preferred StockD Disposition to Issuer—
2025-10-02NEUENeueHealth, Inc.D Disposition to Issuer—
2025-05-21COURCoursera, Inc.A Award—
2025-04-17TRVITrevi Therapeutics, Inc.X Exercise of In-Money+$2.54M
2025-04-17TRVITrevi Therapeutics, Inc. · 3.5-Year Common Stock WarrantX Exercise of In-Money—